Search filters

List of works by Julien Edeline

A multicentre comparison between Child Pugh and Albumin-Bilirubin scores in patients treated with sorafenib for Hepatocellular Carcinoma.

scientific article

A phase I, open-label, single-arm study for QT assessment of eribulin mesylate in patients with advanced solid tumors.

scientific article published on 11 November 2012

Abscopal Effect After SIRT: It Exists, but How Could We Use It?

scientific article published on 15 September 2020

Accelerated MVAC chemotherapy in patients with advanced bladder cancer previously treated with a platinum-gemcitabine regimen.

scientific article published on 22 February 2012

Adverse events of targeted therapies reported by patients with cancer treated in primary care

scientific article published on 01 December 2020

Association of Anti-Programmed Cell Death 1 Antibody Treatment With Risk of Recurrence of Toxic Effects After Immune-Related Adverse Events of Ipilimumab in Patients With Metastatic Melanoma

scientific article published on 15 July 2020

Biomarqueurs prédictifs de réponse aux inhibiteurs de points de contrôle immuns

scientific article published on 01 December 2018

Cementoplasty for painful bone metastases: a series of 42 cases

scientific article published on 17 April 2011

Combination of Temsirolimus and tyrosine kinase inhibitors in renal carcinoma and endothelial cell lines

scientific article published on 10 February 2012

Comparison of tumor response by Response Evaluation Criteria in Solid Tumors (RECIST) and modified RECIST in patients treated with sorafenib for hepatocellular carcinoma.

scientific article

Gemcitabine and Oxaliplatin, but Not Sorafenib or Paclitaxel, Have a Synergistic Effect with Yttrium-90 in Reducing Hepatocellular Carcinoma and Cholangiocarcinoma Cell Line Viability

scientific article published on December 2015

Gemcitabine as second-line chemotherapy after Folfirinox failure in advanced pancreatic adenocarcinoma: A retrospective study.

scientific article

Glass Microspheres 90Y Selective Internal Radiation Therapy and Chemotherapy as First-Line Treatment of Intrahepatic Cholangiocarcinoma

scientific article published on 22 July 2015

Haemolytic uremic syndrome and gemcitabine: jaundice is not always progression in cholangiocarcinoma

scientific article published on 22 February 2012

High impact of macroaggregated albumin-based tumour dose on response and overall survival in hepatocellular carcinoma patients treated with 90 Y-loaded glass microsphere radioembolization.

scientific article published on 11 August 2016

Hilar fat infiltration: A new prognostic factor in metastatic clear cell renal cell carcinoma with first-line sunitinib treatment

scientific article published on 12 June 2017

Implementation of a molecular tumor board at a regional level to improve access to targeted therapy

scientific article published on 25 March 2020

Improved survival prediction and comparison of prognostic models for patients with hepatocellular carcinoma treated with sorafenib

scientific article published on 18 November 2019

Independent association of PD-L1 expression with noninactivated VHL clear cell renal cell carcinoma-A finding with therapeutic potential

scientific article

Intra-Arterial TheraSphere Yttrium-90 Glass Microspheres in the Treatment of Patients With Unresectable Hepatocellular Carcinoma: Protocol for the STOP-HCC Phase 3 Randomized Controlled Trial

scientific article published on 15 August 2018

Medical treatment for cholangiocarcinoma

scientific article published on 01 May 2019

Negative phase 3 study of 90Y microspheres versus sorafenib in HCC.

scientific article published in February 2018

Pembrolizumab Monotherapy for Previously Untreated Advanced Hepatocellular Carcinoma: Data from the Open-Label, Phase II KEYNOTE-224 Trial

scientific article published in 2022

Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial

scientific article published on 06 November 2020

Prognostic scores for sorafenib-treated hepatocellular carcinoma patients: A new application for the hepatoma arterial embolisation prognostic score.

scientific article

Radioembolization Plus Chemotherapy for First-line Treatment of Locally Advanced Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial

scientific article published on 31 October 2019

Selective internal radiation therapy compared with sorafenib for hepatocellular carcinoma with portal vein thrombosis

scientific article

Sorafenib- or 90Y-loaded resin microsphere radioembolization for locally advanced hepatocellular carcinoma, what should we trust?

scientific article published on 02 March 2015

Synchronous Metastatic Clear-Cell Renal Cell Carcinoma: A Distinct Morphologic, Immunohistochemical, and Molecular Phenotype

scientific article published on 27 June 2016

Tivozanib for hepatocellular carcinoma: not likely a new option

scientific article published on 01 November 2020

Usefulness and pitfalls of MAA SPECT/CT in identifying digestive extrahepatic uptake when planning liver radioembolization.

scientific article published on 12 January 2012

Volumetric changes after (90)y radioembolization for hepatocellular carcinoma in cirrhosis: an option to portal vein embolization in a preoperative setting?

scientific article published on 15 March 2013

Yttrium-90 glass microspheres radioembolization (RE) for biliary tract cancer: a large single-center experience

scientific article published on 29 October 2018

[Predictive biomarkers of response to immune checkpoint inhibitors].

scientific article

[Renal cell carcinoma and prognostic factors]

scientific article published on 04 October 2008

[The pathologist's role in the neoadjuvant strategy of renal-cell carcinoma]

scientific article published on 29 November 2011

mRECIST for systemic therapies: More evidence is required before recommendations can be made

scientific article published on 16 March 2017